164 results
8-K
ADAP
Adaptimmune Therapeutics Plc
14 May 24
Submission of Matters to a Vote of Security Holders
7:34am
to authorize the Audit Committee to determine the Company’s auditors’ remuneration for the fiscal year ending December 31, 2024:
For
Against
Abstain
Broker
8-K
EX-10.4
brf0w9
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
unysy6q9
16 May 23
Submission of Matters to a Vote of Security Holders
7:35am